PH26127A - N-(pyridinyl)-1H-indol-1-amines and a process for their preparation - Google Patents

N-(pyridinyl)-1H-indol-1-amines and a process for their preparation Download PDF

Info

Publication number
PH26127A
PH26127A PH36833A PH36833A PH26127A PH 26127 A PH26127 A PH 26127A PH 36833 A PH36833 A PH 36833A PH 36833 A PH36833 A PH 36833A PH 26127 A PH26127 A PH 26127A
Authority
PH
Philippines
Prior art keywords
loweralkyl
compound
formula
hydrogen
indol
Prior art date
Application number
PH36833A
Other languages
English (en)
Inventor
Richard Charles Effland
Joseph Thomas Klein
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of PH26127A publication Critical patent/PH26127A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
PH36833A 1987-04-24 1988-04-22 N-(pyridinyl)-1H-indol-1-amines and a process for their preparation PH26127A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4207987A 1987-04-24 1987-04-24

Publications (1)

Publication Number Publication Date
PH26127A true PH26127A (en) 1992-02-24

Family

ID=21919923

Family Applications (1)

Application Number Title Priority Date Filing Date
PH36833A PH26127A (en) 1987-04-24 1988-04-22 N-(pyridinyl)-1H-indol-1-amines and a process for their preparation

Country Status (17)

Country Link
EP (1) EP0287982B1 (de)
JP (1) JP2683360B2 (de)
KR (1) KR960015003B1 (de)
AT (1) ATE115143T1 (de)
AU (1) AU594876B2 (de)
CA (1) CA1330661C (de)
DE (1) DE3852335T2 (de)
DK (1) DK172153B1 (de)
ES (1) ES2065324T3 (de)
FI (1) FI90978C (de)
IE (1) IE65349B1 (de)
IL (1) IL86154A (de)
NO (1) NO168104C (de)
NZ (1) NZ224338A (de)
PH (1) PH26127A (de)
PT (1) PT87308B (de)
ZA (1) ZA882810B (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4868190A (en) * 1988-12-27 1989-09-19 Hoechst-Roussel Pharmaceuticals, Inc. N-pyridinyl-9H-carbazol-9-amines
US4983615A (en) * 1989-06-28 1991-01-08 Hoechst-Roussel Pharmaceuticals Inc. Heteroarylamino- and heteroaryloxypyridinamine compounds which are useful in treating skin disorders
US5006537A (en) * 1989-08-02 1991-04-09 Hoechst-Roussel Pharmaceuticals, Inc. 1,3-dihydro-1-(pyridinylamino)-2H-indol-2-ones
US5179119A (en) * 1989-08-02 1993-01-12 Hoechst-Roussel Pharmaceuticals Incorporated 1,3-dihydro-1-(pyridinylamino)-2H-indol-1-ones and intermediates for the preparation thereof
DE69016531T2 (de) * 1989-08-02 1995-07-06 Hoechst Roussel Pharma 2,3-Dihydro-1-(pyridinylamino)-indole, Verfahren zu ihrer Herstellung und ihre Anwendung als Arzneimittel.
US5179099A (en) * 1989-08-02 1993-01-12 Hoechst-Roussel Pharmaceuticals Incorporated 2,3-dihydro-1-(pyridinylamino)-indoles
US4983608A (en) * 1989-09-05 1991-01-08 Hoechst-Roussell Pharmaceuticals, Inc. N-substituted-4-pyrimidinamines and pyrimidinediamines
US5102891A (en) * 1990-07-23 1992-04-07 Hoechst-Roussel Pharmaceuticals Inc. 1-(substituted pyridinylamino)-1H-indol-5-yl substituted carbamates
US5214038A (en) * 1991-04-15 1993-05-25 Hoechst-Roussel Pharmaceuticals Inc. 1-(pyrido[3,4-b]-1,4-oxazinyl-4-yl)-1H-indoles and intermediates for the preparation thereof
US5328920A (en) * 1991-04-17 1994-07-12 Hoechst-Roussel Pharmaceuticals Incorporated Substituted (pyridinylamino)-indoles
US5185350A (en) * 1991-09-23 1993-02-09 Hoechst-Roussel Pharmaceuticals Incorporated Substituted pyridinylamino-1h-indoles,1h-indazoles,2h-indazoles, benzo (b)thiophenes and 1,2-benzisothiazoles
US5356910A (en) 1993-07-19 1994-10-18 Hoechst-Roussel Pharmaceuticals Inc. Use of N-(pyridinyl)-1H-indol-1-amines for the treatment of obsessive-compulsive disorder
US5459274A (en) * 1994-05-13 1995-10-17 Hoechst-Roussel Pharmaceuticals Inc. Preparation of N-alkyl-N-pyridinyl-1H-indol-1-amines
US5776955A (en) * 1995-07-27 1998-07-07 Hoechst Marion Roussel, Inc. Use of unsubstituted and substituted n-(pyrrol-1-yl)pyridinamines as anticonvulsant agents
DE69621617T2 (de) * 1995-07-27 2003-01-02 Aventis Pharmaceuticals Inc., Bridgewater Verwendung von substituierten und nichtsubstituierten n-(pyrrol-1-yl)pyridinaminen als antikonvulsiva
JP4256937B2 (ja) * 1996-12-27 2009-04-22 アベンティス・ファーマスーティカルズ・インコーポレイテッド Ｎ−（ピリジニルアミノ）イソインドリン類および関連化合物
EP1035114B1 (de) * 1999-03-10 2004-11-24 Tosoh Corporation Verfahren zur Herstellung Stickstoffheterocyclischer Verbindungen
JP4779185B2 (ja) * 1999-03-10 2011-09-28 東ソー株式会社 含窒素複素環化合物及びその製造方法
JP4683166B2 (ja) * 1999-03-10 2011-05-11 東ソー株式会社 含窒素複素環化合物の製造方法
GB0119435D0 (en) * 2001-02-15 2001-10-03 Aventis Pharm Prod Inc Method of treating of demyelinating diseases or conditions
US7538227B2 (en) 2004-01-13 2009-05-26 Sanofi-Aventis Deutschland Gmbh Process for stabilizing 4-halopyridines
GT200500063A (es) * 2004-04-01 2005-10-14 Metodo para tratar la esquizofrenia y/o anormalidades glucoregulatorias
FR2888238B1 (fr) * 2005-07-07 2007-09-07 Servier Lab Nouveaux derives 1h-indole-pyridinecarboxamides et 1h-indole-piperidinecarboxamide, leur procede de preparation et les compositions pharceumatiques qui les contiennent.
FR2911780A1 (fr) * 2007-01-26 2008-08-01 Urogene Traitement de l'incontinence fecale.
KR20100015546A (ko) * 2007-04-13 2010-02-12 사노피-아벤티스 Ｎ-아미노인돌의 전이 금속 촉매된 합성

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3242185A (en) * 1963-10-07 1966-03-22 Merck & Co Inc Lower aliphatic acids, salts and derivatives thereof
DE1670184A1 (de) * 1967-01-20 1971-01-21 Boehringer Sohn Ingelheim Verfahren zur Herstellung heterocyclisch substituierter Hydrazino-imidazoline-(2)
CH603581A5 (de) * 1974-03-29 1978-08-31 Siegfried Ag
US4260767A (en) * 1979-12-26 1981-04-07 American Cyanamid Company 2-Pyridylhydrazides
US4792562A (en) * 1985-12-04 1988-12-20 Hoechst-Roussel Pharmaceuticals, Inc. N-(pyrrol-1-yl)pyridinamines having memory enhancing activity

Also Published As

Publication number Publication date
IE65349B1 (en) 1995-10-18
DK223488A (da) 1988-10-25
ES2065324T3 (es) 1995-02-16
NZ224338A (en) 1991-07-26
EP0287982A3 (de) 1991-03-27
NO168104C (no) 1992-01-15
KR880012591A (ko) 1988-11-28
JPS63280079A (ja) 1988-11-17
PT87308B (pt) 1992-08-31
DE3852335D1 (de) 1995-01-19
NO881776L (no) 1988-10-25
PT87308A (pt) 1988-05-01
ZA882810B (en) 1988-10-20
FI90978B (fi) 1994-01-14
NO168104B (no) 1991-10-07
FI881874A7 (fi) 1988-10-25
DK223488D0 (da) 1988-04-22
IL86154A0 (en) 1988-11-15
IE881213L (en) 1988-10-24
KR960015003B1 (ko) 1996-10-23
EP0287982A2 (de) 1988-10-26
AU594876B2 (en) 1990-03-15
EP0287982B1 (de) 1994-12-07
DK172153B1 (da) 1997-12-01
JP2683360B2 (ja) 1997-11-26
CA1330661C (en) 1994-07-12
IL86154A (en) 1992-03-29
AU1510088A (en) 1988-10-27
NO881776D0 (no) 1988-04-22
FI90978C (fi) 1994-04-25
DE3852335T2 (de) 1995-05-11
FI881874A0 (fi) 1988-04-21
ATE115143T1 (de) 1994-12-15

Similar Documents

Publication Publication Date Title
PH26127A (en) N-(pyridinyl)-1H-indol-1-amines and a process for their preparation
JP4086663B2 (ja) 新規なスピロ三環式誘導体及びホスホジエステラーゼ７阻害剤としてのそれらの使用
KR102449652B1 (ko) Rock의 억제제로서의 스피로-융합 시클릭 우레아
KR900007780B1 (ko) 축합된 피롤리논 유도체의 제조방법
AU669520B2 (en) Pyrido(2,3-d)pyrimidine derivatives as phosphodiesterase inhibitors
US4492702A (en) 1-Phenyl-1,8-naphthridin-2(1H)-ones
IE50682B1 (en) Imidazo(1,2-a)pyridines,process for their preparation and pharmaceutical compositions containing them
NO894228L (no) Tienopyridiner, fremstilling, mellomprodukter og farmasoeytiske preparater.
EP0934319B1 (de) 1H-PYRIDO[3,4-b]INDOLCARBOXAMIDDERIVATE, IHRE HERSTELLUNG UND THERAPEUTISCHE VERWENDUNG
US4970218A (en) N-(pyridinyl)-1H-indol-1-amines
JPH0568474B2 (de)
US4880822A (en) N-(pyridinyl)-1H-indol-1-amines
JPS63253067A (ja) 新規な置換アニリド誘導体
US5066803A (en) 2- and 3-aminomethyl-6-arylcarbonyl-2,3-dihydropyrrolo[1,2,3-de]-1,4-benzoxazines
US4628055A (en) Method for treating allergic reactions and compositions therefore
EP0623127B1 (de) Verbindungen,die neurotransmitter freisetzen,um die lernfähigkeit zu erhöhen
US5652245A (en) Heterocyclic amines having central nervous system activity
PT90907B (pt) Processo para a preparacao de novas 4,5,7,8-tetra-hidro-6h-tiazolo {5,4-d} azepinas e de composicoes farmaceuticas que as contem
KR100248643B1 (ko) 아릴 및 헤테로아릴 알콕시나프탈렌 유도체
EP0244201B1 (de) 3-Hydroxypyridine
AU613137B2 (en) Pyrazol- and indazolpyridin amines, a process for their preparation and their use as medicaments
JP2807633B2 (ja) Ｎ−（ピリジニル）−ｉｈ−インドール−１−アミンを含有する強迫疾患治療剤
US5109135A (en) 2- or 3-aminomethyl-4-amino-3,4-dihydro-2H-1,4-benzoxazine intermediates
KR900004831B1 (ko) 폴리시클릭퀴놀린, 나프티리딘 및 피라지노피리딘 유도체
US5039811A (en) Preparation of N-(pyridinyl)-1H-indol-1-amines